- Home
- TRVI vs PRG Comparison
TRVI vs PRG Comparison
Compare TRVI & PRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TRVI | PRG |
|---|---|---|
| Founded | 2011 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Diversified Commercial Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.4B |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | TRVI | PRG |
|---|---|---|
| Price | $10.15 | $33.16 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 7 |
| Target Price | $20.38 | ★ $37.67 |
| AVG Volume (30 Days) | ★ 1.3M | 361.9K |
| Earning Date | 03-17-2026 | 02-18-2026 |
| Dividend Yield | N/A | ★ 1.57% |
| EPS Growth | N/A | ★ 10.59 |
| EPS | N/A | ★ 3.96 |
| Revenue | N/A | ★ $2,507,179,000.00 |
| Revenue This Year | N/A | $1.24 |
| Revenue Next Year | N/A | $6.98 |
| P/E Ratio | ★ N/A | $8.38 |
| Revenue Growth | N/A | ★ 3.71 |
| 52 Week Low | $3.73 | $23.50 |
| 52 Week High | $14.39 | $44.43 |
Technical Indicators
Market Signals| Indicator | TRVI | PRG |
|---|---|---|
| Relative Strength Index (RSI) | 34.14 | 66.67 |
| Support Level | $10.17 | $31.85 |
| Resistance Level | $11.15 | $33.45 |
| Average True Range (ATR) | 0.73 | 1.02 |
| MACD | -0.13 | 0.18 |
| Stochastic Oscillator | 3.52 | 88.56 |
Price Performance
Historical ComparisonAbout TRVI Trevi Therapeutics Inc.
Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.
About PRG PROG Holdings Inc.
PROG Holdings Inc is a financial technology holding company that provides transparent and competitive payment options to consumers. The company has two reportable segments: Progressive Leasing, an in-store, app-based, and e-commerce point-of-sale lease-to-own solutions provider; and Vive Financial (Vive), an omnichannel provider of second-look revolving credit products. The majority of the revenue of the company is earned through the Progressive Leasing segment.